KLSC
Overview
Kuwait Life Sciences Company (KLSC) is a venture capital and private equity firm established in 2010 that focuses on the healthcare and life sciences sectors. It invests globally and operates regionally, aiming to advance healthcare services and systems within the Middle East and North Africa (MENA) region. KLSC was established with a paid-up capital of 15 million Kuwaiti Dinars (approx. $53 million USD). In addition to its investment activities, the firm also operates in healthcare training, medical technology, and pharmaceutical distribution. The firm is a wholly-owned subsidiary of the National Technology Enterprises Company (NTEC), which is owned by the Kuwait Investment Authority (KIA), the sovereign wealth fund of Kuwait.
Portfolio Companies
2
Website
klsc.com.kwInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Quanta Dialysis Technologies | Nov 2014 | Series B | Co-investor |
| NewBridge Pharmaceuticals | Sep 2010 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
